Collaborative Stage for TNM 7 - Revised 11/12/2010

LacrimalGland

Lacrimal Gland (excluding Lymphoma)

C69.5

CS Tumor Size
CS Extension
CS Tumor Size/Ext Eval
CS Lymph Nodes
CS Lymph Nodes Eval
Regional Nodes Positive
Regional Nodes Examined
CS Mets at DX
CS Mets Eval
CS Site-Specific Factor 1
Ki-67/MIB-1 Labeling Index (LI): Ophthalmic
CS Site-Specific Factor 2
Nuclear NM23 Staining
CS Site-Specific Factor 3
Clinical Evaluation of Lymph Nodes
CS Site-Specific Factor 4
Perineural Invasion
CS Site-Specific Factor 5
Carcinoma ex Pleomorphic Adenoma, Invasion Beyond Capsule
CS Site-Specific Factor 6
Adenoid Cystic Carcinoma - Presence of Basaloid Pattern
CS Site-Specific Factor 7
Mucoepidermoid Carcinoma - Grade
CS Site-Specific Factor 8
Orbital Bone
CS Site-Specific Factor 9 = 988
CS Site-Specific Factor 10 = 988
CS Site-Specific Factor 11 = 988
CS Site-Specific Factor 12 = 988
CS Site-Specific Factor 13 = 988
CS Site-Specific Factor 14 = 988
CS Site-Specific Factor 15 = 988
CS Site-Specific Factor 16 = 988
CS Site-Specific Factor 17 = 988
CS Site-Specific Factor 18 = 988
CS Site-Specific Factor 19 = 988
CS Site-Specific Factor 20 = 988
CS Site-Specific Factor 21 = 988
CS Site-Specific Factor 22 = 988
CS Site-Specific Factor 23 = 988
CS Site-Specific Factor 24 = 988
CS Site-Specific Factor 25
Schema Discriminator: Lacrimal Gland/Lacrimal Sac
Histology Inclusion Table AJCC 7th ed.
Histology Exclusion Table AJCC 6th ed.
AJCC TNM 7 Stage for sites with no stage groupings
AJCC TNM 6 Stage for sites with no stage groupings
Summary Stage
Extension Size AJCC 7 Table
Extension Size AJCC 6 Table
Revision Info   List of Schemas